The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2019

Filed:

Jan. 24, 2018
Applicant:

B.r.a.i.n. Biotechnology Research and Information Network Ag, Zwingenberg, DE;

Inventors:

Frank Niehaus, Heppenheim, DE;

Jürgen Eck, Bensheim-Auerbach, DE;

Renate Schulze, Bensheim, DE;

Michael Krohn, Lorsch, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/48 (2005.12); A61K 48/00 (2005.12); A61K 38/48 (2005.12); A61K 38/43 (2005.12); C12P 21/00 (2005.12); C12N 15/57 (2005.12); C12N 9/50 (2005.12); C12N 15/52 (2005.12); A61P 17/02 (2005.12); C12N 9/64 (2005.12);
U.S. Cl.
CPC ...
C12N 9/6408 (2012.12);
Abstract

We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds. Described is a nucleic acid molecule encoding a serine protease having the ability to cleave fibrin and casein which is (a) a nucleic acid molecule encoding the serine protease comprising or consisting of the amino acid sequence of SEQ ID NO: 4 as well as to nucleic acid molecules encoding precursors or fragments of said serine protease; (b) a nucleic acid molecule comprising or consisting of the nucleotide sequence of SEQ ID NO: 3; (c) a nucleic acid molecule encoding a serine protease the amino acid sequence of which is at least 80% identical to the amino acid sequence of (a), preferably at least 85% identical, more preferably at least 90% identical, and most preferred 95% identical; (d) a nucleic acid molecule comprising or consisting of a nucleotide sequence which is at least 80% identical to the nucleotide sequence of (b), preferably at least 85% identical, more preferably at least 90% identical, and most preferred 95% identical; (e) a nucleic acid molecule which is degenerate with respect to the nucleic acid molecule of (b) or (d); or (f) a nucleic acid molecule corresponding to the nucleic acid molecule of any one of (a) to (d) wherein T is replaced by U.


Find Patent Forward Citations

Loading…